News Headlines

  1. McKesson Ventures Invests As Clinical Ink Debuts Lunexis ePRO+ Solution 12/3/2020

    Clinical Ink, a global clinical trial technology company, today announced an investment from McKesson Ventures alongside its significantly enhanced electronic patient reported outcome (ePRO) module.

  2. Advarra Acquires Longboat, A Leading Provider Of Site Training, Protocol Compliance, And Patient Engagement Solutions 11/23/2020

    Advarra, the market leader in regulatory review solutions and clinical site technologies, is pleased to announce the acquisition of Longboat, an innovative provider of clinical trial technologies focused on site training, protocol compliance, and patient engagement

  3. Tal Rosenberg To Lead Real World Data At Ciox Health 11/20/2020

    Ciox, a leading health technology company, today announces Tal Rosenberg as President, Real World Data (RWD). A 25-year veteran in creating new value ecosystems and markets at the intersection of Life Sciences and Information Technology, Rosenberg has held various senior leadership roles within technology organizations.

  4. HHS OGC Issues Important Advisory Opinions On The PREP Act 11/18/2020

    On October 23, 2020, the US Department of Health and Human Services Office of the General Counsel (HHS OGC) issued two important Advisory Opinions, 20-03 and 20-04, about the Public Readiness and Emergency Preparedness (PREP) Act and the HHS Secretary’s March 10, 2020, Declaration under the PREP Act for medical countermeasures against COVID-19.

  5. New Greenphire Data Indicates Clinical Trial Industry’s Swift Rebound; Patient Enrollment Reaches Pre-Pandemic Levels 11/9/2020

    Greenphire, the global leader in financial lifecycle management for clinical trials, says patient enrollment for global clinical trials has returned to pre-COVID levels. Research spotlights the need for technological solutions to help participants suffering through financial and logistical hardships to stay enrolled in studies.

  6. Advarra Acquires IntegReview IRB 11/9/2020

    Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), quality and compliance consulting services, and research technology solutions is pleased to announce the acquisition of IntegReview IRB, an AAHRPP-accredited central IRB.

  7. UBC Participates In recent Smallpox Safety Surveillance Study 10/14/2020

    UBC’s participation in a smallpox vaccine study was recently cited in the journal, Vaccine. The prospective study involved the enrollment of 20,136 subjects who were active-duty military personnel undergoing pre-deployment medical readiness. The trial was initiated to address safety concerns related to myopericarditis.

  8. Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center In St. Louis 10/5/2020

    Thermo Fisher Scientific Inc., the world leader in serving science, today announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri.

  9. TrialScope Adds Eisai To Its Community Of Study Sponsors 10/5/2020

    TrialScope, the global leader in clinical trial disclosure and transparency management technology, has added a new study sponsor to its growing customer roster. Eisai Inc. will manage its global clinical trial disclosure compliance process for upwards of 800 studies using the TrialScope DiscloseTM platform.

  10. C3 Summit: Conversations On Clinical Content - A Virtual Discussion On Remote Trial Management And The TMF 10/2/2020

    The C3 Summit is an initiative to bring sponsors, sites, and CROs together throughout the year to share lessons and insights on clinical content collaboration, management, and oversight. The mission of this new online community gathering is to raise awareness for the most practical approaches for improving quality, reducing risks, and increasing speed throughout all stages of a clinical trial.